SNY.TO logo
TSX · SNY.TODrug Manufacturers - GeneralUpdated Oct 25, 2026

Sanofi ROE

Profitability, historical returns, and peer comparisons.

The ROE as of October 2026 (TTM) for Sanofi (SNY.TO) is 5.52%

According to Sanofi’s latest financial reports and current stock price. The company's current ROE is 5.52%. This represents a change of 308.00% compared to the average of 1.35% of the last 4 quarters.

Sanofi (SNY.TO) Historical ROE (quarterly & annually)

How has SNY.TO ROE performed in the past?

The mean historical ROE of Sanofi over the last ten years is 9.98%. The current 5.52% ROE has changed -44.66% with respect to the historical average. Over the past ten years (40 quarters), SNY.TO's ROE was at its highest in in the June 2020 quarter at 12.00%. The ROE was at its lowest in in the December 2025 quarter at -1.12%.

Quarterly (TTM)
Annual

Average

9.98%

Median

8.62%

Minimum

4.67%

Maximum

19.48%

Sanofi (SNY.TO) ROE by Quarter and Year

Discovering the peaks and valleys of Sanofi ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 316.89%

Maximum Annual ROE = 19.48%

Minimum Annual Increase = -53.49%

Minimum Annual ROE = 4.67%

Quarterly (TTM)
Annual
YearROEChange
202510.95%52.59%
20247.17%-1.64%
20237.29%-34.84%
202211.19%23.54%
20219.06%-53.49%
202019.48%316.89%
20194.67%-36.11%
20187.31%-49.54%
201714.49%77.13%
20168.18%10.79%

Sanofi (SNY.TO) Average ROE

How has SNY.TO ROE performed in the past?

The current ROE of Sanofi (SNY.TO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

8.47%

5-year avg

9.13%

10-year avg

9.98%

Sanofi (SNY.TO) ROE vs. Peers

How is SNY.TO’s ROE compared to its peers?

Sanofi’s ROE is less than Merck & Co., Inc. (6.60%), less than Roche Holding AG (37.12%), less than Novo Nordisk A/S (59.09%), less than Eli Lilly and Company (92.58%), less than Novartis AG (29.64%), greater than AbbVie Inc. (-136.50%), less than Pfizer Inc. (4.89%), less than Johnson & Johnson (19.55%), greater than Gilead Sciences, Inc. (0%), less than AstraZeneca PLC (21.68%),

Build a custom stock screener for Sanofi (SNY.TO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sanofi using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sanofi (SNY.TO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sanofi or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Sanofi's ROE?

How is the ROE calculated for Sanofi (SNY.TO)?

What is the highest ROE for Sanofi (SNY.TO)?

What is the 3-year average ROE for Sanofi (SNY.TO)?

What is the 5-year average ROE for Sanofi (SNY.TO)?

How does the current ROE for Sanofi (SNY.TO) compare to its historical average?